Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Starmer refuses to resignCabinet of Ministers issues energy balance decisionRussian army takes control of Yurkovka in Ukraine67 agreements signed in Baku worth $6 billionBus and Changan collide in Hovsan: no injuriesValdas Dambrauskas: Everyone plays football well nowBaku at Center of OIC Anti-Corruption AgendaPeople's Artist Birthday: Agababa BunyadzadeIsDB Head Thanks President for 'Dostlug' OrderFormer Lazio striker loses battle with cancerStarmer refuses to resignCabinet of Ministers issues energy balance decisionRussian army takes control of Yurkovka in Ukraine67 agreements signed in Baku worth $6 billionBus and Changan collide in Hovsan: no injuriesValdas Dambrauskas: Everyone plays football well nowBaku at Center of OIC Anti-Corruption AgendaPeople's Artist Birthday: Agababa BunyadzadeIsDB Head Thanks President for 'Dostlug' OrderFormer Lazio striker loses battle with cancer
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#mineralys

Latest news and interesting information about mineralys.

H.C. Wainwright Reaffirms Mineralys Buy
2026-06-01 12:00
|
842

H.C. Wainwright Reaffirms Mineralys Buy

H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.

ANALYST RATINGS →
0
Mineralys Presents Lorundrostat Data in Kidney Patients
2026-05-30 15:31
|
753

Mineralys Presents Lorundrostat Data in Kidney Patients

Mineralys (MLYS) reveals new clinical data for lorundrostat showing efficacy in hypertensive patients with chronic kidney disease.

COMPANY →
0
...